Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Vera Therapeutics, Inc. shareholders approved Ratification of the selection of KPMG LLP as independent registered public accounting firm at the 2023-05-10 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-05-10
Exact text from the filing
The Company’s stockholders ratified the selection by the Audit Committee of the Company’s Board of Directors of KPMG LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2023. The final voting results are as follows: Votes For Votes Against Abstentions Broker Non-Votes 35,575,486 3,251 12,777 —
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Vera Therapeutics, Inc. shareholders approved Election of three Class II Directors at the 2023-05-10 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-05-10
Exact text from the filing
The Company’s stockholders elected the three persons listed below as Class II Directors, each to serve until the Company’s 2026 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified, or, if sooner, such director’s death, resignation or removal. The final voting results are as follows: Votes For Votes Withheld Broker Non-Votes Maha Katabi, Ph.D. 27,427,581 1,803,342 6,360,591 Michael M Morrissey, Ph.D. 25,666,331 3,564,592 6,360,591 Patrick G. Enright 29,205,775 25,148 6,360,591
View on SEC.gov